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Abstract: In the dimorphism (mold/yeast) Histoplasma capsulatum (Hc) literature are reports that yeast
(the so-called pathogenic form) uniquely expresses a cysteine dioxygenase (CDO, approx. 10,500 dal)
activity which the mold morphotype (the so-called saprophytic soil form) does not express (C.F.,
Kumar et al., Biochem 22, 762, 1983). This yeast-specific CDO activity is postulated to play a critical
role in the mold-to-yeast shift. A number of years ago, our lab isolated the gene encoding the Hc
cysteine dioxygenase (CDO1, Genbank accession AY804144) and noted significant expression in the
mold morphotype of several Histoplasma strains and also determined that the predicted protein would
be over double the 10,500 dal reported by Kumar et al. Our report demonstrates (in the class 1 Downs
strain, the class 2 G271B strain and two Panamanian strains, 184AS and 186AS) that the CDO1 gene is
expressed in both the mold and yeast morphotypes and both morphotypes show significant CDO
activity. Furthermore, we show via a FLAG-tag analysis that the expressed protein is approximately
24.7 ± 2.4 kd, in agreement with the putative protein sequence (determined from cDNA sequence)
which yields 23.8 kd and is consistent with most other eukaryotic CDO enzymes. Additionally, we
demonstrate that intracellular cysteine levels are actually significantly higher in the mold form of the
two Panamanian strains, 184AS and 186AS, equal in both mold and yeast in the class 1 Downs strain
and significantly higher in yeast of the more pathogenic class 2 G217B strain.
Keywords: cysteine dioxygenase; cysteine oxidase; CDO1; Histoplasma dimorphism; mold; yeast
1. Introduction
Histoplasma capsulatum (Hc) is a dimorphic pathogenic fungus that causes histoplasmosis, a common
respiratory disease in humans. It is estimated that approximately 500,000 people are infected each year
in the United States alone [1]—the worldwide incidence, however, must be far greater [2]. Hc grows in
soil in a multicellular mold morphotype but converts to a single-cell yeast morphotype within the
host. This dimorphic shift can be reproduced in the laboratory via changing incubation temperature
from 25 ◦C (mold) to 37 ◦C (yeast). This mold-to-yeast conversion is required for progression of the
disease [3]. Therefore, researchers have sought to understand the molecular biology of Hc dimorphism.
In the late 20th century, it was discovered that sulfhydryl compounds, particularly the amino acid
cysteine, appeared to play a critical role in Hc dimorphism [4,5]. A major hypothesis is that cysteine,
in some fashion, plays a role in intracellular redox which either acts as part of a signal cascade to
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induce the shift into yeast and/or is needed for maintenance of the yeast morphotype [6]. Maresca et al.,
in 1981 [4], reported that a yeast-specific cytosolic cysteine oxidase (CDO; cysteine dioxygenase EC
1.12.11.20) appears early in the mold-to-yeast shift (3–4 days after the 25 to 37 ◦C shift) and hypothesized
that this enzyme is required for dimorphism (i.e., conversion of the mold morphotype into the yeast
morphotype). Kumar et al. [7] reported the purification of Hc CDO and determined the enzyme to
have a molecular weight of 10,500 ± 1,500 daltons and to be highly specific for l-cysteine (converting it,
with O2, to cysteinesulfinic acid; CSA) and reported that it is only present in the yeast morphotype.
Therefore, a common assertation in the Hc literature is that Hc CDO is yeast specific, is approximately
10,500 daltons and plays an important role in dimorphism. Experiments in our lab over the past few
years, however, do not coincide with this literature. Hence, the primary aim of this report is to further
explore expression of the CDO1 gene (previously identified in our lab; GenBank accession AY804144),
CDO enzyme activity and cysteine levels in four strains of Hc. We report here that CDO1 expression
and CDO activity is not yeast specific as there is also significant expression and activity in the mold
morphotype. FLAG-tag expression analysis showed the enzyme is over double the previously reported
size 10.5 kd of Kumar et al. [7] at approximately 24.7 ± 2.4 kd. This value is in agreement with the
putative amino acid sequence, determined from the cDNA, which yields 23.8 kd. Additionally, in
contrast to expectations within the literature, intracellular cysteine levels are generally equal to or
higher in the mold morphotype than the yeast morphotype.
2. Materials and Methods
2.1. Strains and Growth
Histoplasma capsulatum Downs strain (class 1; North American clade 1; NAm 1) was obtained
from ATCC (38904); strains G271B (class 2; NAm 2) and Panama strains (class 3) G184AS and G186AS,
were kind gifts from Bill Goldman at the University of North Carolina. Strain designations and clade
assignments are further described by Keath et al. [8], Kasuga et al., [9], Vincent et al., [10,11] and
Teixeira et al. [12]. Cells were grown to mid log phase in GYE medium (2% w/v glucose, 1% w/v Bacto
yeast extract) to replicate the experiments of Kumar et al., or in HMM defined medium [13]. The
yeast morphotype was grown with gyratory shaking at ~150 rev/min at 37 ◦C. The mold morphotype
was grown with gyratory shaking at 100 rev/min at 25 ◦C. Yeast were harvested by centrifugation at
1000× g for 5 min. Mold cells were harvested by filtration onto a 0.45 um Millipore filter as described
previously [14].
2.2. DNA and RNA Extraction and Blotting
DNA and RNA were extracted from actively growing cells as described previously [14]. Briefly,
cells were harvested by filtration (mold) or centrifugation (yeast) and suspended in RNA buffer (0.1M
sodium acetate, pH 5.0, 0.2M NaCl, 0.2% w/v sodium dodecyl sulfate) or DNA buffer (0.1M Tris pH 8.0,
0.1M EDTA, 0.25M NaCl) along with 0.5 mm glass beads and phenol:chloroform (5:1). The tubes were
agitated until approximately 80% of the cells were broken as determined by microscopic examination.
The nucleic acid was precipitated from the aqueous fraction by adding 2 volumes of ethanol and stored
at −20 ◦C. Northern blotting was performed as previously described [14].
2.3. Quantitative PCR
Primer pairs for CDO1 were designed to yield a product of approximately 112 bp (5′-3′; CDO1F1,
GGGCTTGCATAAAATCTCCA and CDO1R1, CCGTCTTCTCGTCAAAGAGG) were validated (R2
= 0.99; efficiency = 93%). Total RNA was treated with RQ1 RNase-free DNase (Promega) at 37 ◦C
for 30 min according to the manufacturer’s directions to eliminate contaminating DNA. The RNA
was then extracted using phenol:chloroform (5:1) pH = 4.5 and precipitated by adding 1 volume 3M
sodium acetate and 2 volumes of ethanol. The precipitated RNA was harvested by centrifugation and
dissolved in sterile water. The RNA was used to create cDNA with the RETROscript kit (Ambion) with
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random decamers according to the manufacturer’s directions. As an internal control, 18s primers and
competimer mix (2:8) from Quantum RNA 18s kit (Thermo Fisher Scientific) were used. No-template
controls and no-reverse transcriptase controls were also included. For PCR, each 20 µL reaction
contained 10 µL of Full Velocity Sybr Green QPCR mix (Stratagene), 0.2 µL of cDNA, 0.3 µL of
1:500 diluted ROX reference dye (Stratagene), and a final primer concentration of 50 nM of each
primer. Reverse transcriptase was added to a standard reaction (+RT) and minus RT reactions had
no reverse transcriptase. Each of the PCR reactions was done in triplicate on a Mx3000p real-time
thermocycler (Stratagene) as follows: 95 ◦C, 10 min denature; 40 cycles of 95 ◦C 20 s, 60 ◦C 30 s, 72 ◦C
30 s. All real-time quantitative PCR was analyzed with the Mx3000p real-time PCR analysis software
(Stratagene). Assays were performed with triplicate independent RNA preparations.
2.4. Standard and Fusion PCR
The standard PCR reactions were set up with a volume of 25 or 50 µL with 1–10 ng DNA template,
1× Advantage 2 polymerase (Takara Bio) buffer, 0.2 mM each dNTP, 0.2 µM each of forward and
reverse primers and 1× Advantage 2 polymerase. Typical cycling parameters were 30 cycles of the
following: denature at 95 ◦C for 10 s, anneal at 55–68 ◦C for 30 s, and extend at 68–72 ◦C for 1 min/kb
of DNA fragment. Fusion PCR of DNA fragments was performed by the method of Yu et al. [15],
which uses overlapping (nested) primers to create desired constructs.
2.5. CDO Assay
A 100,000× g enzyme extract was prepared according to the method of Kumar et al. [7]. Briefly,
cells were harvested by filtration, resuspended in phosphate buffer (pH 7.0) and broken by ballistic
disruption with glass beads. Protein content was determined by the Bradford assay (BioRad) according
to the manufacturer’s directions. CDO activity was determined by a modification of the method
of Stipanik et al. [16]. Assay buffer (5 mM cysteine-HCl, 2 mM NAD, 5 mM Hydroxylamine HCl,
and 0.25 mM (NH4)2Fe(SO4)2 made in 100 mM PO4 buffer) was prepared fresh for each assay.
A standard curve of cysteine sulfinic acid (CSA, Sigma Aldrich) was made from 5 to 0.005 mM.
A volume of 100 µL of assay buffer was added to 100 µL of the clarified lysate and incubated for 30
min at 37 ◦C. An equal volume of 10% (w/v) trichloroacetic acid (TCA) was added to stop the reaction.
Control reactions had TCA added immediately before the enzyme was added. The solution was
centrifuged at 10,000× g for 5 min to precipitate protein. 200 µL of the supernatant was placed on a
Dowex minicolumn (Sigma Aldrich, approximately 0.3 mL bed volume) and eluted with water. CSA
production was measured by the ninhydrin reaction as follows: 100 µL of the eluate was added to 50
µL of ninhydrin reagent (Sigma Aldrich). The mixture was then incubated at 90 ◦C for 10 min. After
cooling to room temperature, 150 µL of 95% ethanol was added and mixed and the absorbance at
550 nm was measured. These reactions were linear and directly proportional to enzyme added. To
ensure that the assay was, in fact, measuring CSA produced, reactions were also analyzed via thin layer
chromatography on PEI-cellulose plates (Sigma-Aldrich) and compared to authentic CSA. Ascending
chromatography was done by using butanol-acetic acid-water (12:3:5) as the solvent. A standard of 10
to 10 nM of cysteine and CSA was spotted along with samples. After approximately 30 min of solvent
flow, the chromatogram was developed by spraying with Ninhydrin Spray (Sigma) according to the
manufacturer’s directions.
2.6. CDO Flag-Tag Analysis
Genomic DNA of the CDO1 gene with 1.5 kb of its native promoter sequence was used to create
Flag-tag fusions. Fusion PCR was used to attach the sequence for the 8 amino acid FLAG-tag [17]
immediately after (in frame) the putative ATG start codon or immediately before (in frame) the putative
TGA stop codon to yield N-terminal and C-terminal fusions of the CDO1 gene to the C-terminus and
the N-terminus of CDO1, in separate constructs, which were sequenced to confirm proper placement
of the FLAG-TAG. The products were cloned in the Histoplasma telomere vector, pRPUI [18] which
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contains a Ura5 marker for selection. Hc strain 186ASUra5- was electroporated [18] with the plasmid.
pRPUI without the CDO FLAG-TAG fusion was used as a negative control. Protein from transformants
was extracted from mid-log phase cells as follows: cells were washed in ice cold Dulbecco’s PBS three
times and then an equal volume of 0.5 mm glass beads was added. Cells were broken via ballistic
disruption by vortexing on maximum speed on a Vortex Genie (Scientific Industries) for three cycles of
1 min followed by 1 min of cooling in crushed ice. The cells were then centrifuged at 10,000× g for
15 min at 4 ◦C. The clarified lysate (approximately 20 µg protein) was mixed with 10× loading buffer
to yield a final concentration of 0.125 M Tris-HCL buffer (pH 6.8) containing 2% w/v SDS, 10% v/v
glycerol, 5% v/v 2-mercaptoethanol, and 0.025% w/v bromophenol blue. The protein was separated on
a 15% w/v polyacrylamide gel and then blotted onto nitrocellulose membrane. The transfer buffer was
25 mM Tris HCL, 192 mM glycine, and methanol (20% v/v, pH 8.3). Free binding sites of the membrane
were blocked with the incubation of 5% w/v commercial nonfat dry milk in phosphate buffered saline
(PBS), 0.3% Tween 20 (pH = 7.5). The membrane was then probed with an alkaline phosphatase linked
Anti-FLAG antibody (Sigma) according to the manufacturer’s directions.
2.7. Intracellular Cysteine Analysis
To measure the total intracellular cysteine we subjected mid-log phase cells to sulfosalicylic acid
extraction by the method of Dominy et al. [19]. Briefly, cells were extracted with sulfosalicylic acid
followed by reduction with dithiothreitol in 10 N NaOH. The reduced samples were acidified with
glacial acetic acid and reacted with ninhydrin followed by absorbance analysis at 560 nm.
3. Results
3.1. CDO1 Expression
Figure 1 shows a northern blot of total RNA probed with a full-length 32P radiolabeled Hc CDO1
probe. A single transcript of approximately 1.3 kb (compared to RNA standards) was detected in each
strain. This qualitative assay demonstrates that the CDO1 transcript is more abundant in yeast than in
mold, but it is expressed at significant levels in the mold morphotype also. Only a single transcript,
of approximately the same size, was detected in each lane. Figure 2 shows a quantitative determination
of CDO1 expression via real-time quantitative PCR. Although the yeast morphotype demonstrated
greater expression, significant expression of CDO1 was likewise seen in the mold morphotype of all
four strains.
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Figure 1. Northern blot analysis of CDO1 (top) probed with Hc full length 32P-CDO1 compared to 18s
RNA: competimer control (bottom) stripped then probed with 18s 32P-rDNA. M, mold morphotype; Y,
yeast morphotype.
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independent experiments.
3.2. CDO Enzyme Activity
CDO enzyme activity was determined by measurement of CSA production. CDO activity was
more abundant in the yeast morphotype but significant activity was also noted in the mold morphotype
(Figure 3). The Downs yeast had remarkably greater activity than any other strai .
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Figure 3. Cysteine dioxygenase activity. M, mold; Y, yeast. Activity was normalized to protein level
within the extract. Error bars are the standard error of the mean of triplicate independent experiments.
3.3. CDO Molecular Weight
CDO enzyme was determined to have a molecular weight of 25.7 ± 2.4 kd by comparison of both
an N-terminal Flag-tag construct and a C-terminal tagged construct as shown in Figure 4. The 8 amino
acid FLAG-tag would contribute approximately 1 kd to this value, and thus the final estimated Hc
CDO enzyme size is 24.7 kd.
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Figure 4. Western blot of FLAG-tagged Hc CDO probed with anti-FLAG antibody. Lane 1, C-terminus
fusion; Lane 2, N-terminus fusion; Lane 3, no FLAG-tag control; Lane 4, protein MW standard. Size
estimate determined by analysis of three independent blots = 25.7 kDa. Standard deviation was ±
2.4 kDa.
3.4. Intracellular Cysteine Levels
Intracellular cysteine levels (Figure 5) were significantly higher in the mold versus the yeast of the
two Panamanian strains (184AS and 186AS). In strain G217B, however, the mold morphotype had
significantly lower cysteine levels (approximately 67%) than the yeast morphotype. In the Downs
strain, cysteine levels were essentially the same in both the mold and yeast morphotype.
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level. Error bars are the standard error of the mean of triplicate independent experiments.
4. Discussion
Sinc the 1980s, commo assertation within the Histoplasma dimorphism literature is that the
organism has a yeast-specific cystein dioxygenase, of approximately 10,500 daltons, which is thoug t
t play an important role in mold- east dimorphism. In 2004, however, we isolated and sequenced the
Hc CDO1 gene and cDNA (GenBank AY804144.1). The size of the predicted prot in (approx. 24 kd)
was over ouble that reported by Kumar et al. [7]. Additionally, we noted in northern blots that the
CDO1 transcript also present in mold, albeit in lower amounts than in the yeast. Hence, we sought
to investigat expression and activity in four commonly used laboratory strains as well as to
determine the size of the express d protein. Since the Downs strai was used in the original work of
Kumar et al., we likewis included this strain for direct comparison.
As noted in Figure 1, CDO1 was xpr ssed i significant amou ts even in the mold morphotype of
all four strains. Quantitative real-time PCR (Figure 2) demonstrated that the mold morphotypes of all
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four strains also express CDO1. Interestingly, the most pathogenic strain tested, G271B, had dramatically
less expression than the other, less pathogenic, strains. In strain G217B, the mold morphotype expressed
only approximately 1/3 as much CDO1 as the yeast (Y/M = 3.3). This difference in Y vs. M in G217B is
consistent with the ratio determined by Edwards et al. for the same strain [20] (approx. Y/M = 2.4;
https://microbiology.osu.edu/RappleyeHistoplasma). Interestingly, Hwang et al., [21] reported a CDO1
Y/M ratio of 11 in the same G217B strain via genomic shotgun microarray. CDO1 expression in our
study was weakest overall in strain G217B while the other three strains had vastly greater expression.
Approximate ratios (Y/M) for the other three strains were 184AS, 2.0; 186AS, 7.14; Downs, 5.8.
Since it is possible that transcript levels may not equate with enzyme activity, we measured CDO
activity (Figure 3). Again, the mold morphotype of all four strains showed significant CDO activity
albeit not as much as the yeast morphotype. The most striking observation was the dramatic difference
in Y versus M in the Downs strain—the yeast morphotype had approximately 13-fold greater activity
in yeast than in the mold. The other Y/M ratios were 184AS, 1.4; 186AS, 3.6; G217B, 4.3. It is interesting
that the strain examined by Kumar et al., [7] was the Downs strain and this is the strain with the
greatest CDO activity.
Kumar et al., [7] established the molecular weight of the purified CDO enzyme as approximately
10,500 daltons—surprisingly small relative to other known CDO enzymes. Since our northern blot
data (Figure 1) showed that all four strains had CDO1 transcripts of similar size and this is consistent
with our 1.2 kb cDNA sequence (GenBank AY804144.1), we selected the 186AS CDO1 gene to create
FLAG-tag fusions with the 8 amino acid FLAG sequence [17] on either the N-terminus (immediately
after, and in frame, of the putative ATG start codon) or C-terminus (immediately before, and in frame,
of the putative TGA stop codon) in a uracil auxotroph of the same strain. As shown in Figure 3,
identical size bands for both the N-terminal fusion and the C-terminal fusion were seen on western
blots probed with anti-FLAG antibodies. Comparison to molecular weight standards yielded an
estimated size of 25.7 ± 2.4 kd. Once the approximately 1 kd contributed by the 8 amino acid FLAG-tag
is subtracted, the final estimate is approximately 24.7 kd (22.3 to 27.1 kd). The calculated molecular
weight based on the predicted amino acid sequence (GenBank AY804144.1) is 23.8 kd, which is well
consistent with the determination via western blotting.
The reason the much lower 10.5 kd estimate was obtained by Kumar et al. is unknown. The
protein was purified by a cysteine-Sepharose affinity column and then labeled with 125I to enable
detection of the small amounts of protein present. The molecular weight was then determined by SDS
gel electrophoresis as compared to protein molecular weight markers. The researchers commented on
the unusually small size as compared to other known CDO enzymes from eukaryotes. They noted
that rat liver CDO, for example, was approximately double in size and proposed that iodination may
have affected the apparent molecular weight on the SDS gel. However, they ultimately rejected this
hypothesis since a 2D gel analysis of both iodinated and non-iodinated protein demonstrated that
both the iodinated and non-iodinated spot were at the same position on the SDS gel. What then might
account for the low size estimate? Since mobility in SDS gel electrophoresis depends strongly on
proportional binding of SDS micelles, aberrant binding will create errors in molecular weight estimates.
Rath et al., for example, notes that variances of -10% to +30% are well known [22]. These variances,
however, do not seem to able to account for a gel shift as dramatic as 23.8 kd to 10.5 kd. Perhaps
the 10.5 kd protein results from some kind of cleavage during the purification process. In any event,
the 23.8 kd CDO estimate described in this report (Figure 4) is consistent with both the cDNA sequence
data and predicted protein size as well as the size of FLAG-tag constructs and the typical molecular
weights of most eukaryotic CDO enzymes which are generally approximately 23–24 kd, e.g., rat
(GenBank BAA11925), human (BAA12872), mouse (AAK53364), Aspergillus (GCB23511), Phytophtora
(KUF76318), Talaromyces (OKL60606), etc.
The intracellular cysteine levels are also intriguing (Figure 5). Generally, high cysteine (or
other sulfhydryls) in growth media are correlated in the literature with cells growing in the yeast
morphotype—perhaps via providing a more reducing environment. Rippon [23], for example,
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demonstrated that electrolytically lowering the redox of the growth media would allow the
mold-to-yeast shift to occur at the “non-permissive” (for the yeast) temperature of 25 ◦C provided
the medium redox was lowered to +46 mV. Hence, it is postulated that this sulfhydryl compound,
in some manner, alters intracellular redox and thereby, in some manner, affects the signal cascade
and/or the maintenance of the yeast morphotype. Thus, it seems somewhat counterintuitive that the
cysteine levels in the two Panamanian strains (184AS and 186AS) were significantly higher in the mold
than the yeast (Figure 4). The Downs strain had equal levels in both morphotypes and only the more
pathogenic G217B strain demonstrated significantly higher cysteine levels in the yeast.
Clearly the role of CDO and cysteine itself in Hc dimorphism is complex. In future, it would be
useful to create either CDO1 knockout or RNAi knockdown strains. Our numerous attempts to create a
CDO1 knockout have been unsuccessful. Perhaps this is because the knockout is lethal in Hc. However,
the gene has been shown to be non-essential in several organisms. In mice, CDO1 -/- are viable even
without taurine supplementation. In Candida albicans, deletion of the CDO1 homolog, CDG1, resulted
in reduced hypha formation (in the presence of cysteine) and showed reduced virulence in a mouse
model of disseminated infection [24]. However, given the challenge with allelic replacement methods
in Hc, it simply may be that more attempts are required.
We note in this report that there are remarkable differences in the class 1 vs. class 2 strains: Downs
yeast had the highest expression of CDO1 as compared to G217B which had the lowest expression
(Figure 2), and Downs yeast had the greatest CDO enzyme activity by far and G217B the least (Figure 3).
It is curious, however, that Medoff et al. [3] reported that the class 1 strains (Downs) require cysteine
to progress through the mold-to-yeast transition but class 2 strains (e.g., G217B) do not. Perhaps the
Downs strain, and likely other class 1 strains, have a different carbon flow in the cysteine-associated
pathway and/or different sulfur assimilation pathways—this would be an interesting investigation for
the future.
Author Contributions: Both authors contributed equally for this work. All authors have read and agreed to the
published version of the manuscript.
Funding: This work was supported by the Mississippi INBRE, funded by an Institutional Development Award
(IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant
number P20GM103476.
Acknowledgments: The authors thank William Goldman (University of North Carolina) for providing Hc strains.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Hammerman, K.J.; Powell, K.E.; Tosh, F.E. The incidence of hospitalized cases of systemic mycotic infections.
Sabouraudia 1974, 12, 33–45. [CrossRef]
2. Bahr, N.C.; Antinori, S.; Wheat, L.J.; Sarosi, G.A. Histoplasmosis infections worldwide: Thinking outside of
the Ohio River valley. Curr. Trop. Med. Rep. 2015, 2, 70–80. [CrossRef] [PubMed]
3. Medoff, G.; Sacco, M.; Maresca, B.; Schlessinger, D.; Painter, A.; Kobayashi, G.S.; Carratu, L. Irreversible bl
ock of the mycelial-to-yeast phase transition of Histoplasma capsulatum. Science 1986, 231, 476–479. [CrossRef]
[PubMed]
4. Maresca, B.; Lambowitz, A.M.; Kumar, V.B.; Grant, G.A.; Kobayashi, G.S.; Medoff, G. Role of cysteine in
regulating morphogenesis and mit Chondrial activity in the dimorphic fungus Histoplasma capsulatum. Proc.
Natl. Acad. Sci. USA 1981, 78, 4596–4600. [CrossRef] [PubMed]
5. Sacco, M.; Medoff, G.; Lambowitz, A.M.; Kumar, B.V.; Kobayashi, G.S.; Painter, A. Sulfhydryl induced
respiratory “shunt” pathways and their role in morphogenesis in the fungus, Histoplasma capsulatum. J. Biol.
Chem. 1983, 258, 8223–8230.
6. Maresca, B.; Kobayashi, G.S. Dimorphism in Histoplasma capsulatum: A model for the study of cell
differentiation in pathogenic fungi. Microbiol. Rev. 1989, 53, 186–209. [CrossRef] [PubMed]
J. Fungi 2020, 6, 24 9 of 9
7. Kumar, V.; Maresca, B.; Sacco, M.; Goewert, R.; Kobayashi, G.S.; Medoff, G. Purification and characterization
of a cysteine dioxygenase from the yeast phase of Histoplasma capsulatum. Biochemistry 1983, 22, 762–768.
[CrossRef] [PubMed]
8. Keath, E.J.; Kobayashi, G.S.; Medoff, G. Typing of Histoplasma capsulatum by restriction fragment length
polymorphisms in a nuclear gene. J. Clin. Microbiol. 1992, 30, 2104–2107. [CrossRef]
9. Kasuga, T.; White, T.J.; Koenig, G.; McEwen, J.; Restrepo, A.; Castaneda, E.; Da Silva Lacaz, C.;
Heins-Vaccari, E.M.; De Freitas, R.S.; Zancope-Oliveira, R.M.; et al. Phylogeography of the fungal pathogen
Histoplasma capsulatum. Mol. Ecol. 2003, 12, 3383–3401. [CrossRef]
10. Vincent, R.D.; Goewert, R.; Goldman, W.E.; Kobayashi, G.S.; Lambowitz, A.M.; Medoff, G. Classification
of Histoplasma capsulatum isolates by restriction fragment polymorphisms. J. Bacteriol. 1986, 165, 813–818.
[CrossRef]
11. Sepulveda, V.E.; Williams, C.L.; Goldman, W.E. Comparison of phylogenetically distinct Histoplasma strains
reveals evolutionarily divergent virulence strategies. MBio 2014, 5, e01376-14. [CrossRef] [PubMed]
12. Teixeira, M.; Patane, J.S.; Taylor, M.L.; Gomez, B.L.; Theodoro, R.C.; de Hoog, S.; Engelthaler, D.M.;
Zancope-Oliveira, R.M.; Felipe, M.S.; Barker, B.M. Worldwide phylogenetic distributions and population
dynamics of the genus Histoplasma. PLoS Negl. Trop. Dis. 2016, 10, e0004732. [CrossRef]
13. Worsham, P.L.; Goldman, W.E. Quantitative plating of Histoplasma capsulatum without addition of conditioned
medium or siderophores. J. Med. Vet. Mycol. 1988, 26, 137–143. [CrossRef] [PubMed]
14. Tian, X.; Shearer, G. The mold-specific MS8 gene is required for normal hypha formation in the dimorphic
pathogenic fungus Histoplasma capsulatum. Eukaryot. Cell 2002, 1, 249–256. [CrossRef] [PubMed]
15. Yu, J.H.; Hamari, Z.; Han, K.H.; Seo, J.A.; Reyes-Dominguez, Y.; Scazz Cchio, C. Double-joint PCR:
A PCR-based molecular tool for gene manipulations in filamentous fungi. Fungal Genet. Biol. 2004, 41,
973–981. [CrossRef] [PubMed]
16. Stipanuk, M.H.; Dominy, J.E.J.; Ueki, I.; Hirschberger, L.L. Measurement of Cysteine Dioxygenase Activity
and Protein Abundance. Curr Prot. C Toxicol. 2008, 38, 6.15.1–6.15.25. [CrossRef]
17. Hopp, T.P.; Prickett, K.S.; Price, V.L.; Libby, R.T.; March, C.J.; Pat Douglas, C.; Urdal, D.L.; Conlon, P.J. A Short
Polypeptide Marker Sequence Useful for Recombinant Protein Identification and Purification. Bio/Technology
1988, 6, 1204–1210. [CrossRef]
18. Crossley, D.; Naraharisetty, V.; Shearer, G. The Mould-specific M46 gene is not essential for yeast-mould
dimorphism in the pathogenic fungus Histoplasma capsulatum. Med. Mycol. 2016, 54, 876–884. [CrossRef]
19. Dominy, J.E.J.; Hwang, J.; Stipanuk, M.H. Overexpression of cysteine dioxygenase reduces intracellular
cysteine and glutathione pools in HepG2/C3A cells. Am. J. Physiol. End. Crinol. Metab. 2007, 293, E62–E69.
[CrossRef]
20. Edwards, J.A.; Chen, C.; Kemski, M.M.; Hu, J.; Mitchell, T.K.; Rappleye, C.A. Histoplasma yeast and mycelial
transcriptomes reveal pathogenic-phase and lineage-specific gene expression profiles. BMC Genom. 2013, 14, 695.
[CrossRef]
21. Hwang, L.; Hocking-Murray, D.; Bahrami, A.K.; Andersson, M.; Rine, J.; Sil, A. Identifying phase-specific
genes in the fungal pathogen Histoplasma capsulatum using a genomic shotgun microarray. Mol. Biol. Cell
2003, 14, 2314–2326. [CrossRef] [PubMed]
22. Rath, A.; Glibowicka, M.; Nadeau, V.G.; Chen, G.; Deber, C.M. Detergent binding explains anomalous
SDS-PAGE migration of membrane proteins. Proc. Natl. Acad. Sci. USA 2009, 106, 1760–1765. [CrossRef]
[PubMed]
23. Rippon, J.W. Monitored environment system to control cell growth, morphology, and metabolic rate in fungi
by oxidation-reduction potentials. Appl. Microbiol. 1968, 16, 114–121. [CrossRef] [PubMed]
24. Hennicke, F.; Grumbt, M.; Lermann, U.; Ueberschaar, N.; Palige, K.; Bottcher, B.; Jacobsen, I.D.; Staib, C.;
Morschhauser, J.; Monod, M.; et al. Factors supporting cysteine tolerance and sulfite production in Candida
albicans. Eukaryot. Cell 2013, 12, 604–613. [CrossRef]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
